Clinical Trials on Post-ET Myelofibrosis
Total 7078 results
-
CelgeneImpact Biomedicines, Inc., a wholly owned subsidiary of Celgene CorporationAvailable
-
M.D. Anderson Cancer CenterCelgene CorporationCompleted
-
Margherita MaffioliUnknown
-
University Hospital, BrestCompleted
-
Weill Medical College of Cornell UniversityMerck Sharp & Dohme LLCTerminated
-
John MascarenhasNational Cancer Institute (NCI); National Institutes of Health (NIH); Myeloproliferative...CompletedMyelofibrosisUnited States, Canada, Italy, Sweden
-
Weill Medical College of Cornell UniversityCompleted
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingAcute Myeloid Leukemia | Primary Myelofibrosis | Chronic Myelomonocytic Leukemia | Acute Lymphoblastic Leukemia | Myelodysplastic Syndrome | Myeloproliferative Neoplasm | Secondary MyelofibrosisUnited States
-
M.D. Anderson Cancer CenterCephalonCompleted
-
Fred Hutchinson Cancer CenterRecruitingPrimary Myelofibrosis | Secondary MyelofibrosisUnited States
-
Fred Hutchinson Cancer CenterRecruitingPrimary Myelofibrosis | Secondary MyelofibrosisUnited States
-
Ronald HoffmanNational Cancer Institute (NCI); Myeloproliferative Disorders-Research ConsortiumTerminated
-
National Cancer Institute (NCI)Completed
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedChronic Myeloproliferative DisordersUnited States, United Kingdom, France
-
Marina KremyanskayaIncyte CorporationWithdrawnMyelofibrosis | MF
-
Incyte CorporationCompletedMyelofibrosisUnited States
-
M.D. Anderson Cancer CenterIncyte CorporationCompletedMyeloproliferative DiseasesUnited States
-
Geron CorporationCompletedPrimary Myelofibrosis | Secondary Myelofibrosis | Myeloid MalignanciesUnited States
-
Assistance Publique - Hôpitaux de ParisNot yet recruitingMyeloproliferative Neoplasm
-
Sumitomo Pharma America, Inc.RecruitingMyelofibrosisUnited States, Belgium, France, Japan, Australia, Italy, United Kingdom
-
Massachusetts General HospitalIncyte CorporationActive, not recruitingMyelofibrosisUnited States
-
GlaxoSmithKlineNo longer availablePrimary Myelofibrosis | Myelofibrosis
-
Incyte CorporationCompletedMPN (Myeloproliferative Neoplasms)United States, Netherlands, Austria
-
Gruppo Italiano Trapianto di Midollo OsseoCompleted
-
SanofiCompletedMyelofibrosisUnited States
-
Incyte CorporationNovartisCompletedMyelofibrosisFrance, United Kingdom, China, United States, Netherlands, Germany, Italy, Austria
-
Washington University School of MedicineRigel PharmaceuticalsTerminatedMyelofibrosis | ThrombocytopeniaUnited States
-
Central Hospital, Nancy, FranceCompleted
-
M.D. Anderson Cancer CenterHelsinn Healthcare SACompletedMyeloproliferative DiseasesUnited States
-
St. Petersburg State Pavlov Medical UniversityCompletedPrimary Myelofibrosis | Myeloproliferative DisordersRussian Federation
-
Memorial Sloan Kettering Cancer CenterEli Lilly and Company; Incyte CorporationRecruitingMyelofibrosis Due to and Following Polycythemia VeraUnited States
-
Mayo ClinicNational Cancer Institute (NCI)CompletedChronic Myeloproliferative Disorders | Secondary MyelofibrosisUnited States
-
Karyopharm Therapeutics IncRecruitingMyelofibrosis | Moderate ThrombocytopeniaUnited States
-
Universitätsklinikum Hamburg-EppendorfNovartis; Clinical Trial Center North (CTC North GmbH & Co. KG)Active, not recruitingBone Marrow FibrosisGermany
-
CelgeneCompletedPrimary Myelofibrosis | AnemiaUnited States, France, Italy, United Kingdom
-
Universitätsklinikum Hamburg-EppendorfCompleted
-
Center for International Blood and Marrow Transplant...Patient-Centered Outcomes Research Institute; National Marrow Donor ProgramCompletedAdult Hematopoietic Cell Transplant (HCT) Survivors 1-2 Yrs Post Most Recent HCTUnited States
-
Hamad Medical CorporationUnknownEssential Thrombocythemia | Primary Myelofibrosis, Prefibrotic Stage | Primary Myelofibrosis, Fibrotic StageQatar
-
Novartis PharmaceuticalsIncyte CorporationTerminatedMyelofibrosisSpain, United Kingdom, Australia, Israel, Germany, Italy, Singapore, Austria, France
-
Gemin XCompletedMyelofibrosisUnited States, Canada
-
Ryvu Therapeutics SANot yet recruitingMyelofibrosisItaly, Poland
-
University of UtahRecruiting
-
French Innovative Leukemia OrganisationCompleted
-
Center for Vulvovaginal DisordersGeorge Washington University; Gynecologic Cancer Research FoundationUnknown
-
Stanford UniversityCompletedHyperhidrosis | Hyperhidrosis Palmaris et PlantarisUnited States
-
Infinity Pharmaceuticals, Inc.CompletedPrimary Myelofibrosis | Fibrosis, Bone MarrowUnited States
-
OHSU Knight Cancer InstituteNational Cancer Institute (NCI)TerminatedChronic Myeloproliferative DisordersUnited States
-
Humanigen, Inc.SuspendedMyelodysplastic Syndrome (MDS) | Myelofibrosis (MF)United States, Australia
-
Incyte CorporationTerminatedMPN (Myeloproliferative Neoplasms)United States
-
University Hospital, AngersRecruitingEssential Thrombocythemia | Myeloproliferative Disorder | Primary Myelofibrosis, Prefibrotic Stage | Primary Myelofibrosis, Fibrotic StageFrance